CPT code 15793 designates a chemical peel (chemexfoliation), a dermatologic procedure that applies chemical agents to remove superficial scars, sun damage, or acne by controlled exfoliation of the epidermis with variable dermal involvement. This code is relevant nationally for dermatology practices, cosmetic and reconstructive procedures, and payers managing coverage for skin resurfacing therapies. It matters for billing clarity and clinical documentation because the depth of peel and targeted outcomes affect medical necessity determinations and coding consistency. Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical scope, typical sites of service, and the payer landscape addressed in the accompanying publication. The report provides benchmarks used by payers, coding guidance context, and policy or reimbursement updates where available. Clinical context covers indications, agent types, and distinctions in procedural depth that influence coding and coverage. The publication is intended to inform billing staff, dermatology clinicians, and policy analysts about how CPT code 15793 is used in practice, what documentation elements are most relevant, and which payer policies are most likely to affect coverage decisions. Data not available in the input is noted where applicable in detailed sections.